| http://www.w3.org/ns/prov#value | - As noted in the trial data summarized below, women treated with aromatase inhibitors often experience joint pain and musculoskeletal aching, which, in some cases, has necessitated discontinuation of treatment.We review herein the evidence linking aromatase inhibitors and, more broadly, estrogen deprivation, with arthralgias, alerting physicians and other health professionals to this potential prob
|
